T2-weighted endorectal magnetic resonance imaging of prostate cancer after external beam radiation therapy

International Braz J Urol

Volumn 35, Issue 2, 2009, Pages 171-182

  Westphalen, Antonio C ^a   Kurhanewicz, John ^a   Cunha, Rui M G ^a   Hsu, I Chow ^a   Kornak, John ^a   Zhao, Shoujun ^a   Coakley, Fergus V ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Follow up studies; Magnetic resonance imaging; Prostate cancer; Radiotherapy

Indexed keywords

ADJUVANT THERAPY; AGED; ARTICLE; BIOPSY; EVALUATION; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVER VARIATION; PATHOLOGY; PROSTATE; PROSTATE TUMOR; RECTUM; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TUMOR RECURRENCE;

AGED; AGED, 80 AND OVER; BIOPSY; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; OBSERVER VARIATION; PROSTATE; PROSTATIC NEOPLASMS; RECTUM; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 76249100651     PISSN: 16775538     EISSN: 16776119     Source Type: Journal    
DOI: 10.1590/S1677-55382009000200007     Document Type: Article

References (23)

1. Stephenson RA, Stanford JL: Population-based prostate cancer trends in the United States: patterns of change in the era of prostate-specific antigen. World J Urol. 1997; 15:331-5.
2. Kestin LL, Vicini FA, Ziaja EL, Stromberg JS, Frazier RC, Martinez AA: Defining biochemical cure for prostate carcinoma patients treated with external beam radiation therapy. Cancer. 1999; 86: 1557-66.
3. Moul JW: Prostate specific antigen only progression of prostate cancer. J Urol. 2000; 163: 1632-42.
4. Pollack A, Zagars GK, Antolak JA, Kuban DA, Rosen II: Prostate biopsy status and PSA nadir level as early surrogates for treatment failure: analysis of a prostate cancer randomized radiation dose escalation trial. Int J Radiat Oncol Biol Phys. 2002; 54: 677-85.
5. Vance W, Tucker SL, de Crevoisier R, Kuban DA, Cheung MR: The predictive value of 2-year post-treatment biopsy after prostate cancer radiotherapy for eventual biochemical outcome. Int J Radiat Oncol Biol Phys. 2007; 67: 828-33.
6. Rouvière O: MR assessment of recurrent prostate cancer after radiation therapy. Radiology. 2007; 242: 635-6; author reply 636-7.
7. Chan TW, Kressel HY: Prostate and seminal vesicles after irradiation: MR appearance. J Magn Reson Imaging. 1991; 1:503-11.
8. Coakley FV, Hricak H, Wefer AE, Speight JL, Kurhanewicz J, Roach M: Brachytherapy for prostate cancer: endorectal MR imaging of local treatment-related changes. Radiology. 2001; 219: 817-21.
9. Coakley FV, Teh HS, Qayyum A, Swanson MG, Lu Y, Roach M 3rd, et al.: Endorectal MR imaging and MR spectroscopic imaging for locally recurrent prostate cancer after external beam radiation therapy: preliminary experience. Radiology. 2004; 233: 441-8.
10. Pucar D, Shukla-Dave A, Hricak H, Moskowitz CS, Kuroiwa K, Olgac S, et al.: Prostate cancer: correlation of MR imaging and MR spectroscopy with pathologic findings after radiation therapy-initial experience. Radiology. 2005; 236: 545-53.
11. Rouvière O, Valette O, Grivolat S, Colin-Pangaud C, Bouvier R, Chapelon JY, et al.: Recurrent prostate cancer after external beam radiotherapy: value of contrast-enhanced dynamic MRI in localizing intra-prostatic tumor--correlation with biopsy findings. Urology. 2004; 63: 922-7.
12. Sala E, Eberhardt SC, Akin O, Moskowitz CS, Onye-buchi CN, Kuroiwa K, et al.: Endorectal MR imaging before salvage prostatectomy: tumor localization and staging. Radiology. 2006; 238: 176-83.
13. Haider MA, Chung P, Sweet J, Toi A, Jhaveri K, Ménard C, et al.: Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy. Int J Radiat Oncol Biol Phys. 2008; 70: 425-30.
14. Pickett B, Kurhanewicz J, Coakley F, Shinohara K, Fein B, Roach M 3rd: Use of MRI and spectroscopy in evaluation of external beam radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2004; 60: 1047-55.
15. D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA, et al.: Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA. 1998; 280: 969-74.
16. Roach M 3rd, Hanks G, Thames H Jr, Schellhammer P, Shipley WU, Sokol GH, et al.: Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-AS-TRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys. 2006; 65: 965-74.
17. Wefer AE, Hricak H, Vigneron DB, Coakley FV, Lu Y, Wefer J, et al.: Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology. J Urol. 2000; 164: 400-4.
18. Obek C, Louis P, Civantos F, Soloway MS: Comparison of digital rectal examination and biopsy results with the radical prostatectomy specimen. J Urol. 1999; 161: 494-8; discussion 498-9.
19. Scheidler J, Hricak H, Vigneron DB, Yu KK, Sokolov DL, Huang LR, et al.: Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging--clinicopathologic study. Radiology. 1999; 213:473-80.
20. Pucar D, Hricak H, Shukla-Dave A, Kuroiwa K, Drobnjak M, Eastham J, et al.: Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: magnetic resonance imaging and step-section pathology evidence. Int J Radiat Oncol Biol Phys. 2007; 69: 62-9.
21. Kestin LL, Goldstein NS, Vicini FA, Mitchell C, Gus-tafson GS, Stromberg JS, et al.: Pathologic evidence of dose-response and dose-volume relationships for prostate cancer treated with combined external beam radiotherapy and high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys. 2002; 54: 107-18.
22. Padhani AR, Mac Vicar AD, Gapinski CJ, Dearnaley DP, Parker GJ, Suckling J, et al.: Effects of androgen deprivation on prostatic morphology and vascular permeability evaluated with mr imaging. Radiology. 2001; 218: 365-74.
23. Hawkins DM, Garrett JA, Stephenson B: Some issues in resolution of diagnostic tests using an imperfect gold standard. Stat Med. 2001; 20: 1987-2001.